| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/17/2007 | CN1895544A Diabetes treatment for tonifying Qi and nourishing Yin by dried rehmannia root radix asparagi and figwort root |
| 01/17/2007 | CN1895543A Diabetes treatment for clearing heat and moistening dryness by Sheng Di, dwarf lilyturf tuber and figwort root |
| 01/17/2007 | CN1895534A Diabetes treatment for clearing heat, relieving fire and nourishing Yin |
| 01/17/2007 | CN1895533A Diabetes treatment for tonifying spleen and nourishing kidney by Tangshen, atractylodes rhizome and Chinese magnoliavine fruit |
| 01/17/2007 | CN1895510A Diabetes treatment by prepared rehmannia root, asiatic cornelian cherry fruit and Indian bread Yang-warm and kidney-nourishing |
| 01/17/2007 | CN1895509A Diabetes treatment by solomonseal rhizome, desert cistanche and fleeceflower root blood-activation and obstruction-remove |
| 01/17/2007 | CN1895508A Diabetes treatment by common yam Rhizome, snake gourd root and Chinese wolfberry root-bark clear heat and cool blood |
| 01/17/2007 | CN1895506A Treatment of diabetes mellitus by common Yam Rhizome, dried rehmannia root and prepared common monkshood daughter root |
| 01/17/2007 | CN1895476A Chongcao Emiao oil capsules and preparation thereof |
| 01/17/2007 | CN1895437A Blood-fat-reducing beverage |
| 01/17/2007 | CN1895414A Chinese-medicinal preparation for treating high blood fat and its making method |
| 01/17/2007 | CN1895400A Treatment of diabetes for reinforcing kidney and strengthening Qi by milkvetch, white peony root and kudzuvine root |
| 01/17/2007 | CN1895399A Chinese-medicinal preparation for treating early diabetic retinopathy |
| 01/17/2007 | CN1895393A Halth-care composition for regulating blood fat |
| 01/17/2007 | CN1895372A Health-care foot-soaking liquid for diabetes and its preparation |
| 01/17/2007 | CN1895366A Chinese medicine for treating hyperlipemia |
| 01/17/2007 | CN1895314A Sanchi total saponin free-dried powdery injection against smash and its preparation |
| 01/17/2007 | CN1895293A Spirulina oral tablet for supplementing human-body nutrients and its preparation |
| 01/17/2007 | CN1895288A Lactic acid bacteria tablet with alimentary health-care function and its preparation |
| 01/17/2007 | CN1895283A Production of nanometer biological calcium agent from aquatic animal bones and shells |
| 01/17/2007 | CN1895282A Calcium supplementary agent and its preparation |
| 01/17/2007 | CN1895250A Gliquilone slow-releasing preparation |
| 01/17/2007 | CN1895239A Curcumin preparation and its making method |
| 01/17/2007 | CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament |
| 01/17/2007 | CN1294936C Medicine for treating diabetes and its preparation method |
| 01/17/2007 | CN1294908C Oral gliclazide sustained release formulation |
| 01/17/2007 | CN1294848C Protein powder fat-reducing foodstuff with low heat quantity and balanced nutrition |
| 01/17/2007 | CN1294828C Producing method of red rice fat reducing tea |
| 01/17/2007 | CN1294827C Preparing process of antihyperglycemic tea with functions of inhibiting cholesterol synthesis |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163952 Azole compound and medicinal use thereof |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163940 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 01/16/2007 | US7163932 Aryldifluoromethylphosphonic acids for treatment of diabetes |
| 01/16/2007 | CA2234233C Retrievable bioartificial implants |
| 01/16/2007 | CA2219742C N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 01/16/2007 | CA2182620C Improving glucose tolerance |
| 01/16/2007 | CA2103996C Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 01/11/2007 | WO2007005503A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/11/2007 | WO2007005453A2 Compositions for treating or preventing obesity and insulin resistance disorders |
| 01/11/2007 | WO2007005320A2 Methods of delivering corticotroph-derived glycoprotein hormone |
| 01/11/2007 | WO2007004960A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer’s desease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson’s disease |
| 01/11/2007 | WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 01/11/2007 | WO2007004957A1 Novel crystalline form |
| 01/11/2007 | WO2007004733A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 01/11/2007 | WO2007004570A1 Composition having physical endurance improving effect and/or anti-fatigue effect |
| 01/11/2007 | WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 01/11/2007 | WO2007004523A1 Pharmaceutical composition and beverage composition comprising l-arginine |
| 01/11/2007 | WO2007004405A1 Stealth cells |
| 01/11/2007 | WO2007004390A1 Cachexia improving preparation and cachexia improving food |
| 01/11/2007 | WO2007004244A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof |
| 01/11/2007 | WO2007003964A1 G-protein coupled receptor agonists |
| 01/11/2007 | WO2007003960A1 Gpcr agonists |
| 01/11/2007 | WO2007003581A1 Phenoxy acetic acids as ppar delta activators |
| 01/11/2007 | WO2007003419A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/11/2007 | WO2007003365A1 Pharmaceutical composition comprising simvastatin and ezetimibe |
| 01/11/2007 | WO2006108818A3 Trimeric peptides for use in treating obesity |
| 01/11/2007 | WO2006074390A3 Methods of treating obesity with combination therapeautics of igf-i fusion polypeptides |
| 01/11/2007 | US20070010671 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/11/2007 | US20070010585 Compounds having strong beta -galactosidase inhibitory activity or beta -glucosidase inhibitory activity; excellent solubility; pseudo-sugar; excellent treatment or prevention of glycolipid metabolic disorders |
| 01/11/2007 | US20070010581 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 01/11/2007 | US20070010569 4-Methyl-5-(2-oxo-1,2-dihydroindol-3- ylidenemethyl)-1H-pyrrole-2- carboxylic acid; cancer |
| 01/11/2007 | US20070010562 Nr1h4 nuclear receptor binding compounds |
| 01/11/2007 | US20070010535 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological atates |
| 01/11/2007 | US20070010529 Nitrogenous heterocyclic compounds and medical use thereof |
| 01/11/2007 | US20070010526 Therapeutic isoquinoline compounds |
| 01/11/2007 | US20070010517 Pharmaceutical salts of reboxetine |
| 01/11/2007 | US20070010515 [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof |
| 01/11/2007 | US20070010483 Glucocerebroside treatment of liver disorders |
| 01/11/2007 | US20070010479 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070010456 Therapeutic agents for low HDL-cholesterolemia |
| 01/11/2007 | US20070010423 Compositions comprising balaglitazone and further antidiabetic compounds |
| 01/11/2007 | US20070010030 Complement C3 precursor biopolymer markers indicative of insulin resistance |
| 01/11/2007 | US20070009963 Apolipoprotein biopolymer marker indicative of normal human |
| 01/11/2007 | US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 01/11/2007 | US20070009597 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/11/2007 | US20070009513 Novel method of screening |
| 01/11/2007 | US20070009498 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 01/11/2007 | DE102004040736B4 Verfahren zur Herstellung von Diarylcycloalkylderivaten A process for preparing Diarylcycloalkylderivaten |
| 01/11/2007 | CA2614347A1 Pharmaceutical composition comprising simvastatin and ezetimibe |
| 01/11/2007 | CA2614315A1 Activator of peroxisome proliferator activated receptor d |
| 01/11/2007 | CA2614116A1 Histamine h3 receptor antagonists |
| 01/11/2007 | CA2614017A1 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 01/11/2007 | CA2613636A1 Compositions for treating or preventing obesity and insulin resistance disorders |
| 01/11/2007 | CA2613365A1 Phenoxy acetic acids as ppar delta activators |
| 01/11/2007 | CA2613236A1 G-protein coupled receptor agonists |
| 01/11/2007 | CA2613235A1 Gpcr agonists |
| 01/11/2007 | CA2613192A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/11/2007 | CA2612591A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/11/2007 | CA2610213A1 Infant nutrition with hydrolised proteins |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/10/2007 | EP1741710A1 Pyrrolidine derivative |
| 01/10/2007 | EP1741704A1 Method for increasing specific surface area of slightly soluble drug |
| 01/10/2007 | EP1741703A1 Pyridone derivative |
| 01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 01/10/2007 | EP1741447A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/10/2007 | EP1741446A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |